Even indian pharma cant afford to test phases of any new medicine. only pharma MNC can do it. indian companies are only interested in making generic versions. though indian companies able to research new molecules, they intend to sell it before clinical trials.
4.08 PM Apr 21st
TOUGH STAND ON USA: India is signalling that it will talk about american firms in india when usa is talking about indian IT firms to hire americans in usa. last week India also signalled usa that if us fda can issue observations to indian pharma companies exporting to usa, india will also do
11.29 AM Apr 21st
companies are now ready for USFDA inspection which is a good news. In fact Indian Pharma companies were caught with their pant down like dirty toilet, leaking roof, food of workers in refrigerator meant for samples. Now they have changed and again ready to lead the global pharma manufacture and supply
7.12 PM Apr 12th
US FDA is bullish in Indian pharma refer to the report as Indian pharma cos get 55 final ANDA approvals from US FDA in Q1 of 2017 , Aurobindo Phama remained on top with 13 ANDA approvals and 3 tentative approvals during first quarter ended March 2017. Lupin and Zydus Pharma Group captured second
12.37 PM Apr 7th